CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
52.06
+1.07 (2.10%)
Apr 28, 2026, 4:00 PM EDT - Market closed
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.01 billion as of April 28, 2026. Its market cap has increased by 48.75% in one year.
Market Cap
5.01B
Enterprise Value
3.25B
1-Year Change
48.75%
Ranking
Category
Stock Price
$52.06
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.01B, an increase of 795.25%. That is a compound annual growth rate of 25.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 5.00B | -0.01% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 5.52B |
| TG Therapeutics | 5.41B |
| Scholar Rock Holding | 5.34B |
| Xenon Pharmaceuticals | 5.27B |
| Apellis Pharmaceuticals | 5.24B |
| Corcept Therapeutics | 4.94B |
| Dianthus Therapeutics | 4.76B |
| Ligand Pharmaceuticals | 4.61B |